ReviewFrontiers in microbiology2026
Viral vectors for antimicrobial peptide expression: a new path for crop protection.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transforming Plant Viruses into Vectors for Next-Generation Agriculture-A Review.Current microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial peptides (AMPs) are key components of plant innate immunity, offering broad spectrum protection against pathogens and represent promising alternatives to chemical pesticides for sustainable crop protection. Despite their broad range antimicrobial activity and low potential for resistance development, the deployment of AMPs in agriculture has been severely limited by instability, poor bioavailability and the lack of efficient, field-compatible delivery strategies. Harnessing viral vectors as platforms for AMP expression in plants represents a powerful strategy to enhance plant innate immunity. This review provides an overview of the potential of viral vectors for transient gene expression, functional genomics and genome editing. We discuss the design, construction and delivery of viral vectors, as well as the main challenges associated with AMP expression, including cytotoxicity and stability. Finally, inspired by adeno-associated virus (AAV) mediated AMP delivery strategies in mammals, we propose a vaccine-like strategy for plant protection, in which viral vectors enable endogenous AMP production Although plants lack adaptive immunity, virus-mediated AMP expression may function as a biochemical analog, reinforcing basal defence layers and enhancing tolerance to pathogen infection. By integrating viral biotechnology with plant defence mechanisms, this approach could redefine the future of sustainable agriculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.